Interestingly, it has been shown that not all DN patients had C3 deposition and that C3 deposition was significantly more in late DN than early DN, suggesting that complement activation may be an aggravating factor rather than a causative factor (27, 29). This evidence concerns the gene C3 and liver dysplastic nodule.